Murepavadin Uses, Dosage, Side Effects and more
Murepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment).
Attribute | Details |
---|---|
Trade Name | Murepavadin |
Generic | Murepavadin |
Murepavadin Other Names | Murepavadin |
Type | |
Formula | C73H112N22O16 |
Weight | Average: 1553.837 Monoisotopic: 1552.862665614 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |